Center for Financial Planning Inc. Sells 261 Shares of CVS Health Co. (NYSE:CVS)

Center for Financial Planning Inc. lessened its stake in shares of CVS Health Co. (NYSE:CVS) by 15.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,441 shares of the pharmacy operator’s stock after selling 261 shares during the period. Center for Financial Planning Inc.’s holdings in CVS Health were worth $65,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the 3rd quarter worth $25,000. Ridgewood Investments LLC increased its stake in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC bought a new position in shares of CVS Health in the 4th quarter valued at $28,000. Livelsberger Financial Advisory bought a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Finally, Legacy Investment Solutions LLC bought a new position in shares of CVS Health in the 3rd quarter valued at $31,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the topic of several recent analyst reports. Barclays lifted their price target on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a research note on Thursday. StockNews.com upgraded CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday. UBS Group cut their price objective on CVS Health from $62.00 to $59.00 and set a “neutral” rating on the stock in a report on Tuesday. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a report on Thursday, January 30th. Finally, Mizuho cut their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $70.28.

CVS Health Stock Down 1.0 %

Shares of NYSE:CVS opened at $65.71 on Friday. The company has a market capitalization of $82.68 billion, a price-to-earnings ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The business’s 50-day moving average is $50.90 and its 200-day moving average is $56.01. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Equities research analysts predict that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.05%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s dividend payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.